Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
3(33%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_4
1
11%
Ph not_applicable
6
67%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Recruiting3
unknown1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 41 (11.1%)
N/A6 (66.7%)

Trials by Status

completed333%
unknown111%
terminated111%
withdrawn111%
recruiting333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9